Skip to main content

Table 6 Relationships between changes in serum adipokines and changes in laboratory parameters of inflammation or disease activity at months 6 and 12 (R2: goodness-of-fit from linear regression)

From: Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study

R2 Time of assessment ESR CRP IL-6 DAS28-ESR
Total adiponectin M6 0.99 0.98 0.89 0.93
M12 0.78 0.75 0.88 0.64
HMW adiponectin M6 0.92 0.93 0.99 0.76
M12 0.67 0.64 0.94 0.42
Leptin M6 0.37 0.46 0.09 0.53
M12 0.81 0.81 0.36 0.94
leptin/fat mass M6     
M12 0.91 0.45 0.96 0.91
Resistin M6 0.19 0.11 0.51 0.08
M12 0.26 0.31 0.27 0.51
Ghrelin M6 0.32 0.31 0.74 0.01
M12 0.09 0.04 0.23 0.07
  1. HMW high molecular weight
\